Company intelligence / Profile preview

CollPlant Biotechnologies

Rehovot, Israel
Ownership
Public · CLGN
Employees
~57
Development stage
Other
01

Overview

CollPlant's key regenerative breast implant program has shown promising early animal data with evidence of tissue regeneration and neovascularization, as well as a promising safety profile. The dermal filler program partnered with AbbVie has entered the clinical phase with interim human data being reviewed by AbbVie as of 2025. Preclinical data supports safety and efficacy for wound healing and tendon healing products.[7][6][2]

Therapeutic areas
Women's HealthDermatologyRheumatologyOther
Modalities
Recombinant proteinBiologicBioinkPhotocurable hydrogelMedical device
Industry
Biotech
02

Drug pipeline

3 assets

photocurable regenerative dermal filler

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

AbbVie (Allergan) – worldwide exclusive license for dermal and soft tissue fillersSTEMCELLStratasysAdvanced Regenerative Manufacturing InstituteRegenMed Development Organization

Beyond the preview

Go deeper on CollPlant Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CollPlant Biotechnologies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call